# Zepatier For Treatment Of Hepatitis C-Negative Patients Who Receive Heart Transplants From Hepatitis C-Positive Donors (HCV)

> **NCT03146741** · PHASE1,PHASE2 · COMPLETED · sponsor: **University of Pennsylvania** · enrollment: 20 (actual)

## Conditions studied

- Heart Failure

## Interventions

- **DRUG:** Zepatier

## Key facts

- **NCT ID:** NCT03146741
- **Lead sponsor:** University of Pennsylvania
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-05-16
- **Primary completion:** 2019-09-10
- **Final completion:** 2019-11-30
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2021-11-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03146741

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03146741, "Zepatier For Treatment Of Hepatitis C-Negative Patients Who Receive Heart Transplants From Hepatitis C-Positive Donors (HCV)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03146741. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*